ECSP066631A - VARIATIONS OF IMMUNOGLOBULINS AND USE OF THE SAME - Google Patents
VARIATIONS OF IMMUNOGLOBULINS AND USE OF THE SAMEInfo
- Publication number
- ECSP066631A ECSP066631A ECSP066631A ECSP066631A EC SP066631 A ECSP066631 A EC SP066631A EC SP066631 A ECSP066631 A EC SP066631A EC SP066631 A ECSP066631 A EC SP066631A
- Authority
- EC
- Ecuador
- Prior art keywords
- immunoglobulins
- variations
- same
- malignant
- antibodies
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 abstract 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención proporciona anticuerpos humanizados y quiméricos anti-CD20 para el tratamiento de enfermedades malignas y autoinmunes positivas para CD20.The invention provides humanized and chimeric anti-CD20 antibodies for the treatment of malignant and autoimmune diseases positive for CD20.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52616303P | 2003-12-01 | 2003-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP066631A true ECSP066631A (en) | 2006-10-25 |
Family
ID=40433445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP066631 ECSP066631A (en) | 2003-12-01 | 2006-06-09 | VARIATIONS OF IMMUNOGLOBULINS AND USE OF THE SAME |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP066631A (en) |
-
2006
- 2006-06-09 EC ECSP066631 patent/ECSP066631A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050649B1 (en) | Immunoglobulin variants and uses thereof | |
| DOP2006000029A (en) | ANTIBODY VARIANTS AND USES THEREOF. (VARIATIONS OF AN ANTIBODY AND USES OF THE SAME) | |
| TNSN06133A1 (en) | Immunoglobulin variants and uses thereof | |
| DK1613347T3 (en) | Humanized antibodies that recognize beta amyloid peptide | |
| HRP20181459T1 (en) | Humanized anti-beta7 antagonists and uses thererfor | |
| CY2012019I1 (en) | HUMAN MONOCLONAL ANTIBODIES AGAINST CD20 | |
| MY176959A (en) | Humanized antibodies that recognize beta amyloid peptide | |
| MX2025000260A (en) | Anti-steap1 antigen-binding protein | |
| DK1773885T3 (en) | Humanized anti-c-met antagonists | |
| ITMI20031127A1 (en) | ANTI-HGF-R ANTIBODIES AND THEIR USE | |
| CY1113243T1 (en) | METHODS OF TREATMENT USING CTLA-4 | |
| CR9562A (en) | ANTI-CD40 HUMANIZED ANTIBODIES AND THEIR METHODS OF USE | |
| UY29283A1 (en) | AB (BETA) ANTIBODIES USED TO IMPROVE COGNITION | |
| PE20091193A1 (en) | HUMAN ANTIGEN BINDING PROTEINS FROM GM-CSF | |
| EA202191769A1 (en) | TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES | |
| EA201891499A1 (en) | CHEMICAL DOG ANTI-CD20 ANTIBODY | |
| ECSP066631A (en) | VARIATIONS OF IMMUNOGLOBULINS AND USE OF THE SAME |